DEFERASIROX TARO

/ Taro International Ltd

For patients > 2 years old:
For patients regularly receiving blood transfusions – 20 mg per kilogram body weight.
For patients who do not regularly receive blood transfusions – 10 mg per kilogram body weight
The maximum daily dosage is:
• 40 mg per kilogram body weight for patients regularly receiving blood transfusions.
• 20 mg per kilogram body weight for adult patients not regularly receiving blood transfusions.
• 10 mg per kilogram body weight for children aged under 18 years not regularly receiving blood transfusions
Please refer to the license holder for further details.

Treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over). Also indicated for the treatment of chronic iron overload in patients with non–transfusion-dependent thalassemia syndromes aged 10 years and older. Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC]≥5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 μg/l). LIC is the preferred method of iron overload determination and should be used wherever available

* Hypersensitivity
* Moderate or severe kidney disease
* Concomitant use of another chelating agent

Please refer to the license holder for further details.

Please refer to the license holder for further details.

Please refer to the license holder for further details.

Please refer to the license holder for further details.

Please refer to the license holder for further details.